<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10502697</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Moñux Martínez, A</dc:author>
<dc:author>Toledano Muñoz, A</dc:author>
<dc:author>Galindo Campillo, A N</dc:author>
<dc:author>Bernáldez Millán, R</dc:author>
<dc:author>Gavilán Bouzas, J</dc:author>
<dc:description xml:lang="en">Thromboembolism is a risk in major surgical procedures on the head and neck for cancer in predisposed patients. This study was designed to determine if preoperative administration of low-molecular-weight heparin is safe or if it increases the risk of postoperative complications. Preoperative administration of low-molecular-weight heparin was the most important factor in complications such as pharyngo-cutaneous fistula, wound infection, suture dehiscence, or seroma. The second most important factor was surgical technique, and the third factor was neck dissection. Low-molecular-weight heparin did not reduce the risk of thromboembolism. In fact, one patient died suddenly from thromboembolism after surgery.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Aug-Sep </dc:date>
<dc:title xml:lang="es">Profilaxis tromboembólica en pacientes con carcinomas de cabeza y cuello: un estudio riesgo-beneficio.</dc:title>
<dc:title xml:lang="en">[Thromboembolic prophylaxis in patients with head and neck carcinomas: a risk-benefit study].</dc:title>
<dc:publisher>Acta otorrinolaringologica espanola</dc:publisher>
</metadata>
</record>
</pubmed-document>
